CereMark Pharma, LLC
Quick facts
Phase 3 pipeline
- [F-18]Flornaptitril · Cardiovascular
Flornaptitril is a beta-2 adrenergic receptor agonist.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: